Trial Profile
A Phase I, Open Label, Single Sequence,Drug Interaction Study Evaluating Plasma GSK1349572 and Tenofovir Pharmacokinetics in Healthy Adult Subjects (ING111604)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatitis B; HIV infections
- Focus Pharmacokinetics
- Sponsors GSK
- 27 Oct 2008 Trial end date changed from 1 Sep 2008 to 1 Oct 2008 as reported by ClinicalTrials.gov.
- 27 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Sep 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.